Importantly, the ESC/EAS 2019 guidelines for the treatment of dyslipidaemias strongly recommend the use of total apoB as an integral index for the entirety of atherogenic, apoB-containing lipoprotein particles [4]. This evidence concerns the gene APOB and inherited lipid metabolism disorder.